|
HS Code |
907267 |
| product_name | H-DL-Leu-OH |
| synonym | DL-Leucine |
| chemical_formula | C6H13NO2 |
| CAS_number | 61-90-5 |
| appearance | White crystalline powder |
| solubility_in_water | Slightly soluble |
| melting_point | 293°C (dec.) |
| optical_activity | Racemic (DL mixture) |
| pKa1 | 2.33 |
| pKa2 | 9.74 |
| usage | Amino acid, used in research and food industry |
As an accredited H-DL-Leu-OH factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | H-DL-Leu-OH is supplied in a sealed amber glass bottle containing 25 grams, labeled with product details and safety information. |
| Shipping | H-DL-Leu-OH is shipped in secure, sealed containers to prevent contamination and degradation. Packaging complies with standard chemical safety regulations, typically including labeled bottles within protective secondary containment. The product is shipped at ambient temperature unless otherwise specified, with documentation and Material Safety Data Sheet (MSDS) included to ensure regulatory compliance and safe handling. |
| Storage | H-DL-Leu-OH (DL-Leucine) should be stored in a tightly sealed container, protected from moisture and light. Keep it in a cool, dry place at room temperature (15–25°C). Avoid exposure to strong oxidizing agents. For long-term storage, refrigeration (2–8°C) may be recommended. Ensure the storage area is well-ventilated and complies with standard chemical safety protocols. |
Applications of H-DL-Leu-OH in Industrial ManufacturingH-DL-Leu-OH, the DL-form of leucine with a free carboxylic acid group, plays a specialized role as a non-proteinogenic amino acid intermediate in targeted chemical synthesis. Below, we detail the real-world industrial application scenarios where manufacturers utilize this raw material as a key input for controlled downstream processes. 1. Peptide Synthesis for Pharmaceutical IntermediatesManufacturers use H-DL-Leu-OH to introduce the leucine residue into synthetic peptide chains during the solid-phase or solution-phase synthesis of active pharmaceutical ingredient (API) intermediates. This amino acid derivative enables precise sequence design when D/L stereochemistry is not restricted by pharmacological pathways. Specific conditions depend on the peptide chain length and required chiral purity, with the raw material integrated after initial deprotection steps and before coupling reactions. Pharmaceutical-grade processing requires stringent adherence to international quality and traceability protocols to support regulated drug substance production. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Customized Nutraceutical Additive FormulationNutraceutical manufacturers use this racemic leucine derivative as a raw input for research-grade supplements and as a flavor precursor in nutritional products. While L-leucine dominates food-grade blends, the DL form is applied where enantiomeric purity is not critical, such as in customized amino acid cocktails tested for novel metabolic effects in animal feed or pre-market dietary prototypes. Application requires compliance with regional food safety standards and documentation of raw material origin and batch traceability. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Chiral Intermediate in Agrochemical SynthesisAgrochemical manufacturers employ H-DL-Leu-OH as a starting material in the stereoselective synthesis of specialized crop protection agents and biochemical actives. The DL form is selected for downstream conversion into either single-enantiomer or racemic agrochemical intermediates, facilitating controlled synthesis steps in both hydrophilic and hydrophobic target molecules. Raw material input must follow strict chemical quality controls and documentation for use in regulated agricultural product supply chains. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Chemical Standard for Analytical LaboratoriesAccredited laboratories and reference material suppliers use H-DL-Leu-OH to prepare calibration standards and control samples for amino acid analysis. Its role as a primary or secondary reference material supports HPLC, GC, and electrophoretic quantification of D- and L-leucine in complex matrices. Application requires documentation of source, batch records, and certificate of analysis for traceability under laboratory quality systems. Laboratory application batches differ in purity and impurity profiles from production-grade material. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive H-DL-Leu-OH prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Producing H-DL-Leu-OH means dealing with a molecule built for reliability in both research and industrial settings. This alpha-amino acid, chemically referred to as DL-Leucine, often finds its way into peptide synthesis and various biotechnological processes. Our own experience with its manufacturing has taught us that keeping a consistent stereochemistry blend—a racemic mixture of D- and L-isomers—opens doors for broader application than the pure L-form or D-form alone. Chemists and production managers alike appreciate its flexibility, especially where specificity to chirality is less important than functional performance or price.
From our process viewpoint, the practical impact of the racemate has always stood out. Handling both enantiomers in a single feed simplifies sourcing and logistics. During the scale-up stages, we found that this not only smooths out the supply chain but also helps to rein in costs without shortchanging end-use performance in assays or synthesis. The properties—white crystalline appearance, neutral odor, and easy handling thanks to a predictable melting point—allow operators and lab staff to work with less waste and minimal fuss.
In our reactors, H-DL-Leu-OH moves from raw material to finished intermediate under tightly controlled conditions. Because the molecule serves as a key building block in peptide coupling, its purity sets the baseline for everything downstream. We always target high chemical purity but focus with equal attention on keeping moisture at bay, as even trace amounts seep into final quality. Our QC teams have chased microcontaminants in the past, so we test batches regularly for residual solvents and metals. The hard-won lesson here: small investments in cleanrooms and better solvent removal pay off in fewer batch failures and reinforced trust from our partners.
Users in custom peptide manufacturing often come back to H-DL-Leu-OH for experiments where the optical purity of the final product won’t make or break the result. Because it mixes D- and L-forms, it grants greater availability and keeps pricing competitive. Researchers, especially in scale-up pilot plants or teaching labs, see notable benefit from such versatility. We also encountered growing interest in the molecule from combinatorial chemistry groups, who value the blend for screening compound libraries. By supplying kilogram quantities, we lower the cost-of-entry and foster a culture of accessible science.
After years at the production line, certain differences stand out between H-DL-Leu-OH and its pure chiral relatives. Customers routinely ask why someone would choose the racemate over the pure L-leucine or D-leucine. The answer generally comes down to three factors: application, regulatory environment, and economics. Our experience shows most pharmaceutical actives demand a single enantiomer, usually L-leucine, because living systems show stereoselectivity. On the other side, preliminary studies, diagnostic kit development, and some feedstock uses place less emphasis on chirality. Here, the racemate shines, offering chemical equivalence for testing hypotheses at a savings that can be substantial.
From a granular production standpoint, synthesizing the racemate requires different controls. Optically pure L-leucine, for example, may demand fermentation with specific microbes, bioengineering, or multiple separation steps. These drive up both turnaround time and cost per kilogram. Making the racemate involves less specialized separation and sometimes leverages straightforward chemical synthesis from α-bromo acids or similar intermediates. This efficiency lets us offer material at quantities reaching hundreds of kilograms per batch with lead times that few chiral suppliers can beat.
Our direct relationships with long-standing customers shed light on new, sometimes unexpected uses for H-DL-Leu-OH. Aside from standard roles in peptide assembly, we have supported its use as a reference material for analytical instrumentation calibration. Quality control managers tell us that the balance of both enantiomers creates more robust benchmarks in chiral separation method development. Colourless, odorless, and stable across a wide pH range, it serves as a reliable yardstick for HPLC and TLC workflows. As a manufacturing team, this feedback pushes us to keep the specification sheet honest, track heavy metal content, and support in-process analytics with lot-to-lot consistency.
Cosmetics and nutraceuticals have also turned to racemates for certain blends and tablet formulations. While L-leucine dominates most dietary supplement manufacturing, exploratory R&D arms in these sectors test racemic samples for formulation tolerance and ingredient interaction studies. We once worked closely with a partner investigating emulsion stability and particle dispersion, where the symmetrical properties of DL systems altered product texture in subtle but beneficial ways. Years of batch data tell us that physical stability—whether under agitation or prolonged shelf storage—stems from our drying technique, not just base chemistry.
Every order starts with a real discussion between technical staff and production managers. We don’t operate in an ideal world—batch-to-batch variance, changing regulatory guidelines, and raw supply hiccups keep everyone on their toes. In our experience, honest feedback cycles build more resilient supply lines. For H-DL-Leu-OH, we refuse to cut corners on our release protocols. Before it ships, the material goes through a series of physical and spectral checks: moisture content, appearance, melting range, even an IR spectral scan when impurities rear their head. Any spike in ash content or unwanted trace elements gets back-tracked to its source—almost always a raw vendor drifting from agreed limits.
Of all products in our amino acid portfolio, this one brings the fewest surprises in warehousing and transport. A tight particle size specification guards against dusting and clumping in high-speed filling lines. This speeds up order fulfillment and protects against stuck valves, a pain point familiar to anyone moving fine powders in bulk bags or drums. Having troubleshooting teams on both warehouse and end-user floors keeps rework rates low, and in almost a decade’s record, only a handful of shipments have needed recall or reprocessing.
Customers request greater transparency in both process and environmental footprint. Several years ago, we swapped out certain halogenated solvents for greener alternatives—not just to score points in audits, but to keep plant workers safer and reduce downstream waste. Our ongoing investments in solvent recovery and re-circulation brought over 20% reduction in direct process emissions since those changes.
The tweaks didn’t come overnight. One early trial led to lower-than-expected yields due to incomplete crystallization; after troubleshooting flow rates and solvent ratios, we landed on a process adjustment that delivers over 98% yield in routine operations. These lessons stick across product lines: what boosts yield or reduces energy in H-DL-Leu-OH often translates to other racemate amino acids we manufacture.
Several end-users, especially in university and government research settings, ask for more information about energy profiles and input sourcing. We now include voluntary green metrics upon request—tracking solvent use and batch energy consumption as a part of our growing effort to back up quality claims with real, measured data. We see peers moving in this direction too, and hope stricter standards become the rule rather than the exception.
No manufacturing commentary survives without a nod to supply chain realities. Prices in the amino acid space shift quickly, and our own raw material partners sometimes bump up lead times or push for updated terms. During the recent freight crunch, we doubled down on forecasting and kept buffer stocks on hand. That decision saved several contracts from collapse, especially in European and North American export markets, where delayed rail and ocean shipments created bottlenecks for peers working on just-in-time systems.
H-DL-Leu-OH’s stable chemical profile makes it a reliable candidate for stockpiling, and customers building buffer inventories look to us to understand which grades will hold up through prolonged storage. Our data shows that sealed drums in dry, cool conditions maintain full quality for at least two years, giving users the flexibility to ride out short-term market or policy shocks. One lesson learned: long-term contracts with raw suppliers win every time over spot purchases, both in terms of guaranteed quality and out-the-door price.
Manufacturers can’t talk about chemicals without touching safety. H-DL-Leu-OH isn’t considered hazardous by major regulators if you follow common sense handling. Still, our team takes pride in keeping dust under control and offering clear guidelines to customers on PPE and storage. Employees train annually on spill containment, while documentation teams update SDS forms the moment a process tweak arises. Our experience and that of our customers confirm that well-labelled, clearly packaged product prevents misunderstandings at the dock and keeps processing lines moving efficiently. We see all of our clients as partners who share in the responsibility of workplace safety.
Our own staff work hard to keep community relations strong. Neighbors occasionally tour our facilities and ask about emissions or noise. Our doors remain open, always responding to inquiries with transparency and respect. One lesson ring true in manufacturing: community trust builds on years of reliable operation, not just glossy brochures or ISO certificates.
As a company grounded in practice, we always encourage users to communicate honestly about intended use. H-DL-Leu-OH performs predictably as long as expectations match technical reality. For those running pilot batches or scaling up, it pays to pilot the material in parallel with your process water, buffers, and substrates to flag cross-reactivity or physical changes before moving to full-scale runs. We’ve seen teams minimize time and material loss with thoughtful dry runs, especially for new processes or automated lines.
For anyone on the fence about racemate versus optically pure forms, we suggest reviewing target application specs and speaking frankly with both R&D and procurement teams. If cost drivers and chiral constraints align, the racemate serves as a sound choice. Reach out with unique requirements: our ability to tailor drying, particle size, or purity has helped many clients avoid bottlenecks, whether optimizing for solution rates or bulk handling.
We’ve seen H-DL-Leu-OH gain traction year after year, partly because the product keeps up with the changing needs of pharmaceutical, biotech, and analytical sectors. Our batch records stretch back over a decade, each entry a testimony to lessons learned and problems solved. The molecule may not grab headlines, but it sits near the core of reliable peptide assembly, cost-effective screening, and flexible feedstock management.
Every plant manager here knows that maintaining long-term value takes more than just technical expertise. We listen carefully to what labs, pilot plants, and commercial operations ask for—not just on spec sheets, but in feedback sessions, technical troubleshooting calls, and the quiet moments when a shipment hits its deadline just as a new project begins.
Manufacturing H-DL-Leu-OH wouldn’t work without paying attention to what really matters: dependable raw material, actionable feedback, supplier honesty, and community engagement. It’s the accumulated experience—down to the lessons learned from a faulty batch valve or a customer call at midnight—that guides our next round of process tweaks or product improvements. The story of H-DL-Leu-OH stands as an ongoing dialogue between manufacturing realities and research ambitions, always focused on quality, transparency, and real-world value.